TrialArthritis research & therapy2008

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.

Richard Furie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.